Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The incus, commonly known as the anvil, is one of the three small bones (ossicles) located in the middle ear of mammals. It serves a critical role in the auditory system by transmitting sound vibrations from the malleus to the stapes, which then passes the signal to the inner ear. While the incus is essential for normal hearing, it is an anatomical structure rather than a molecular therapeutic target such as a receptor or enzyme. Pathologies involving the incus, such as ossicular chain discontinuity or otosclerosis, are typically addressed through surgical intervention or prosthetic replacement rather than pharmacological targeting of the bone itself. Consequently, it does not possess a molecular classification, drug interactions, or a biochemical mechanism of action in the context of drug discovery.
Not applicable as the incus is an anatomical structure, not a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Incus.